Product Quality For Cell Therapies

This session is set to be a compelling exploration of product quality in Cell Therapies.

Key areas of focus include:

As the field of regenerative medicine and Cell Therapies advances, it underscores a longstanding imperative: the quality, safety, and efficacy of these products has always been and remains the most crucial aspect of any therapy.

While a multi-faceted approach to quality is a standard across various therapies, Cell Therapies present unique challenges due to their nature as living therapies. Specifications for these products will inherently exhibit a range because they are derived from living cells. Consequently, testing strategies for Cell Therapies are more risk-based and require a tailored approach when compared to non-Advanced Therapy Medicinal Products (non-ATMPs).

  • Understanding Cell Therapies
  • The Importance of Product Quality
  • Building a Quality Strategy
  • Testing and Validation
  • Regulatory Landscape

Our experts can provide insights and answer your queries to advance your cell therapy development. This webinar is designed to help you explore and navigate the complexities of product quality strategies for cell therapies. If you have additional questions, we invite you to share them.

NecstGen Services

We offer process development solutions, contract preclinical/ GMP manufacturing and cleanroom rental for Cell and Gene Therapies to clinicians, academic, small, medium, and large commercial organisations worldwide.

Viral Vector Manufacturing & Development

Cleanroom Rental

Cell Therapy Manufacturing & Development

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and
capacity to focus on patient solutions.

NecstGen

Team

Partners

History

Facility